Close mobile menu×
Close mobile menu

Jason D. Wright, MD

Board Certifications: 
Gynecologic Oncology, Obstetrics and Gynecology
Expertise in: 
Gynecologic Cancers, Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-3410

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Gynecologic Oncology
  • Obstetrics and Gynecology

Clinical Expertise

  • Gynecologic Cancers
  • Cancer Care
  • Laparoscopic Surgery
  • Gynecological Surgery
  • Pelvic Floor Surgery
  • Gynecological Laparoscopic Surgery
  • Laparoscopic Hysterectomy
  • Gynecologic Cancer Surgery

Education & Training

  • Kansas City School of Medicine, University of Missouri
  • Internship: Barnes Jewish Hospital-Washington University School of Medicine
  • Residency: Barnes Jewish Hospital-Washington University School of Medicine
  • Fellowship: Barnes Jewish Hospital-Washington University School of Medicine

About Jason Wright

Jason Wright, MD – Chief of Gynecologic Oncology at ColumbiaDoctors

Dr. Wright joined the faculty at Columbia University after completing residency and a fellowship in Gynecologic Oncology at Washington University in St. Louis. He is board certified in Obstetrics and Gynecology and Gynecologic Oncology. Dr. Wright sees women with all gynecologic cancers and has extensive training in minimally invasive surgery, robotic surgery, extended pelvic resections, and pelvic reconstructive surgery. Dr. Wright also cares for a large number of women with hereditary cancer syndromes. In addition, Dr. Wright sees women with who require complex gynecologic procedures as well as women with placenta accreta.

Dr. Wright is a nationally recognized expert in the treatment of gynecologic cancers and gynecologic surgery. He has authored over 110 articles, chapters, and textbooks. A major focus of Dr. Wright's work is the delivery of quality care to women with cancer and the improvement of outcomes of women with cancer and those who undergo surgery. Dr. Wright's primary clinical research focuses on the evaluation of novel therapeutics, targeted therapies and biologic treatments for women with gynecologic cancers. Dr. Wright is the principal investigator on a number of clinical trials and an active participant in the Gynecologic Oncology Group (GOG). Dr. Wright is a member of the Alpha Omega Alpha (AOA) Honor Society, a full member of the Society of Gynecologic Oncology, and a Fellow of the American College of Obstetricians and Gynecologists. Dr. Wright has won numerous teaching and research awards and lectures throughout the United States and internationally.

Academic Titles

  • Sol Goldman Associate Professor of Gynecologic Oncology (in Obstetrics and Gynecology)

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 305-3410
Fax:
(212) 305-3412
Primary
2
51 West 51st Street
New York, New York 10019
Phone: (212) 305-3410
Fax:
(212) 305-3412

Research

Grants

A BLINDED PROSPECTIVE STUDY OF THE PERFORMANCE OF HE4 TO PREDICT RECURRENCE IN PATIENTS WITH ADVANCED OVARIAN CANCER, PERITONEAL CARCINOMA AND TUBAL CARCINOMA (P&S Industry Clinical Trial)

Oct 28 2014 - Oct 28 2019

A MULTICENTER PROSPECTIVE STUDY OF CA 125 AND HE4 SERUM BIOMARKERS FOR MONITORING THE RESPONSE TO FIRST-LINE THERAPY IN WOMEN WITH PRIMARY EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCERS (P&S Industry Clinical Trial)

Oct 28 2014 - Oct 28 2019

COMORBIDITY, TOXICITY AND BREAST CANCER SURVIVAL AMONG WOMEN ON AND OFF CLINICAL TRIALS (Private)

Aug 2 2016 - Aug 1 2019

USING SWOG-MEDICARE DATABASE TO EVALUATE LONG-TERM TOXICITIES OF CANCER SURVIVORS (Federal Gov)

Feb 15 2013 - Jan 31 2018

BREAST CANCER ACCESS TO CARE AND DISPARITIES RESEARCH PROGRAM (Private)

Jan 1 2017 - Dec 31 2017

THE INFLUENCE OF HOSPITAL VARIABILITY ON THE MANAGEMENT OF CANCER-ASSOCIATED COMPLICATIONS (Federal Gov)

Jan 1 2013 - Dec 31 2017

H3E US-X073 (P&S Industry Clinical Trial)

Nov 28 2011 - Nov 28 2016

MORAB-003-004 (P&S Industry Clinical Trial)

Nov 23 2011 - Nov 23 2016

A PHASE 3 PLACEBEO-CONTROLLED STUDY OF CARBOPLATIN/PACLITAXEL WITH OF WITHOUT CONCURRENT AND CONTINUATION MAINTENANCE (Private)

Oct 8 2015 - Oct 7 2016

HIPPOCOMPAL AND COGNITIVE FUNCTION, EXERCISE, AND OVARIAN CANCER: A PILOT STUDY (Federal Gov)

Aug 1 2014 - Jul 31 2016

INFLUENCE OF GEOGRAPHIC VARIATION ON ACCESS TO MINIMALLY INVASIVE GYNECOLOGIC CANCER SURGERY (Private)

Jul 1 2015 - Jun 30 2016

MCH RESEARCH (Federal Gov)

Apr 1 2015 - Mar 31 2016

PHASE II EVALUATION OF CARBOPLATIN,PACLITAXEL AND BEVACIZUMANEOADJUVANT THERAPY FOR EPITHELIAL OVARIAN (P&S Industry Clinical Trial)

May 20 2010 - May 20 2015

ONCOFISH CERVICAL TEST FOR DETECTION OF 3Q26 REGION GAIN (P&S Industry Clinical Trial)

Jun 8 2009 - Dec 31 2014

THERAPEUTIC TARGETING OF NOTCH IN OVARIAN CANCER (Federal Gov)

Jul 1 2009 - Jul 31 2013

ACCEPTANCE OF HUMAN PAPILLOMAVIRUS VACCINATION IN POSTPARTUMWOMEN (P&S Industry Clinical Trial)

May 30 2009 - May 30 2012